Powerful lab and computational techniques developed by scientists at Weill Cornell Medicine and two other centers will enable scientists to map tumors’ ability to develop resistance to drugs.
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
With a grant of $2,355,000 over five years, Marcos Simoes-Costa, assistant professor of molecular biology and genetics, will investigate how the spatial complexity of an organism is generated in early development.
New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
The Department of Global Development will draw from faculty across the College of Agriculture and Life Sciences to create a unified development studies program.
A Cornell doctoral student is deploying new satellite technology that may be used for space research in the future and help New York farmers make more informed decisions today about growing crops and caring for animals.
Cornell researchers have put a new spin on measuring and controlling spins in nickel oxide, with an eye toward improving electronic devices’ speed and memory capacity.
A Cornell-led team of engineers has discovered a crystalline material with ultralow thermal conductivity – thus, the ability to turn heat into electricity.
